Journal of ethnopharmacology
Cure8 research brief
Why This Matters
People with UC may be interested because the study identifies a traditional herbal formulation that reduced disease markers in a mouse model and changed gut microbiota and inflammatory pathways (IL‑17), suggesting possible new complementary treatment leads to investigate further.
However, these are animal and lab results, not evidence that the medicine is effective or safe in people yet.
Who Should Pay Attention
Researchers studying IBD therapeutics, microbiome and immune pathways; clinicians interested in emerging preclinical IBD research; patients curious about experimental complementary therapies (with caution).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This PubMed abstract reports a preclinical (mouse and in vitro) study of a traditional Chinese ethnomedicine, Fufang Tongye Shaoshang You (TYY), tested in a DSS-induced ulcerative colitis mouse model.
The authors measured disease activity, colon histology, organ function markers, analyzed transcriptomic targets and 16S rRNA microbiota changes, and identified seven circulating bioactive components with in vitro validation in LPS‑stimulated Caco-2 cells.
TYY improved disease measures in mice, was associated with inhibition of IL-17 signaling, modulation of the gut microbiota, and protection of the intestinal mucosal barrier; seven candidate bioactive compounds were prioritized by serum pharmacochemistry.
The report frames TYY as a potential complementary oral therapy for UC based on these mechanistic preclinical findings. This is a preclinical mechanistic study (mouse and cell models) reported as an abstract in the Journal of Ethnopharmacology; it does not provide clinical data in humans.
Applications to patient care require clinical trials and safety evaluation in people. Avoid assuming equivalent effects or safety in humans based on these results.
Keep In Mind
This is a preclinical study (mouse and cell experiments) reported as an abstract; it does not substitute for clinical trials. Journal of Ethnopharmacology focuses on traditional medicines; further independent replication and human safety/efficacy studies would be needed before clinical use.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of ethnopharmacology
AuthorsYuting Lu, Yuping Dai, Yan Duan +5 more
InstitutionSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan, 410208, China; Hunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, Changsha, Hunan, 410208, China; Hunan Province Sino-US International Joint Research Center for Therapeutic Drugs of Senile Degenerative Diseases, Changsha, Hunan, 410208, China; School of Medicine, Guangxi University of Science and Technology, Liuzhou, Guangxi, 545005, China; Guangxi College Key Laboratory of Innovation Research on Medical and Engineering Integration & Liuzhou Key Laboratory of Guizhong Characteristic Medicinal Resources Development, Liuzhou, Guangxi, 545005, China. Electronic address: 2008022@gxust.edu.cn.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedApr 15, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The polysaccharide from Usnea longissima ach. ameliorates DSS-induced ulcerative colitis by restoring gut microbiota homeostasis and inhibiting the NF-κB/PI3K-Akt signaling pathways.
Researchers are exploring natural compounds that may modulate gut microbes, barrier function, and immune signaling relevant to ulcerative colitis.
Synergistic effects of heat-clearing and yin-nourishing herbs in compound Ganlu Yin on attenuating ulcerative colitis in mice
The study explores a multi-herb formula that the authors report reduces inflammation and alters gut microbiota in a mouse model of ulcerative colitis, suggesting possible biological mechanisms worth further study.
Gut commensal Lachnospira eligens alleviates ulcerative colitis by mediating isodeoxycholic acid via the STAT3/NF-κB signaling pathway
The study identifies a specific gut microbe and a bile-acid metabolite that reduced inflammation in a mouse colitis model and implicates STAT3/NF-κB pathways — a potential new avenue for microbiome-based therapeutics for...